Ameriprise’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Ameriprise’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.8M	Sell	943,449 -65,793	-7%	-$1.66M	﹤0.01%	1417
2026 Q1	$25.5M	Sell	1,009,242 -773,096	-43%	-$19.7M	0.01%	1254
2025 Q4	$45.3M	Buy	1,782,338 +74,744	+4%	+$1.91M	0.01%	933
2025 Q3	$43.8M	Buy	1,707,594 +899,251	+111%	+$22.8M	0.01%	966
2025 Q2	$20.2M	Buy	808,343 +171,517	+27%	+$4.26M	0.01%	1346
2025 Q1	$15.9M	Buy	636,826 +38,584	+6%	+$954K	﹤0.01%	1457
2024 Q4	$14.7M	Buy	598,242 +556,331	+1,327%	+$13.9M	﹤0.01%	1535
2024 Q3	$1.08M	Buy	41,911 +12,514	+43%	+$316K	﹤0.01%	3191
2024 Q2	$722K	Buy	29,397 +9,037	+44%	+$221K	﹤0.01%	3301
2024 Q1	$505K	Buy	+20,360	New	+$504K	﹤0.01%	3409

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Ameriprise's IBDX Position: Q2 2026 in Review

Ameriprise reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 6.5% in Q2 2026, selling an estimated $1.66M and leaving 943,449 shares worth $23.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

Ameriprise first reported a position in IBDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $45.3M in Q4 2025. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

Ameriprise held 943,449 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $23.8M as of Q2 2026.
Ameriprise sold 65,793 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $1.66M.
iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1417 holding.
Ameriprise first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
Ameriprise's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $45.3M in Q4 2025.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.